Bing Xu is a Research Scientist at the Masonic Medical Research Institute (MMRI) since July 2018, focusing on the role of macrophage RhoA signaling in cardiac repair and remodeling. Prior to this, Bing Xu has been a Postdoctoral Research Scientist at Cedar Sinai Medical Center since February 2014, investigating the regulation and remodeling of BIN1-induced membrane microdomains in cardiomyocytes during heart failure progression. Bing Xu holds a Ph.D. in Molecular Biology from China Agricultural University, obtained between 1998 and 2001.